Trulieve Introduces New Products to Massachusetts for February

TALLAHASSEE, Fla., Feb. 3, 2023 /PRNewswire/ — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve ” or “the Company”), a leading and top-performing cannabis company in the United States, today announced the February launch of two of its proprietary brands in Massachusetts, Roll One on February 3 and Modern Flower on February 10.

“It’s an exciting time for Massachusetts’ cannabis market as we continue to expand our offerings and introduce proprietary brands in this growing state,” said Kim Rivers, CEO of Trulieve. “Trulieve continues to focus on providing high-quality cannabis and offering a wide variety of innovative products that fit our customer’s needs and budget.”

The two new product introductions in Massachusetts are:

• Roll One – Launching statewide on February 3, this is quality cannabis at an everyday value. The brand’s indoor-grown flower is expertly tended to by industry-leading cultivators at local state-of-the-art facilities. Flower options will feature classic, quality strains available in a variety of increments including 7g ground flower, 3.5g whole flower, and 1g pre-rolls. Roll One is also introducing a new product to the Massachusetts market with a pre-roll 4-pack.
• Modern Flower – Launching statewide on February 10, Modern Flower focuses on accessibility, quality, and reliability. Created for modern cannabis consumers with everyday use in mind, these popular indoor-grown strains and innovative products are created with cutting-edge technologies. These options are a combination of modern potencies and affordability, with a diverse set of offerings – so everyone can enjoy a new and Modern approach to cannabis. Available on launch day will be whole flower, 1g pre-rolls, and more coming soon.

Roll One is also available at Trulieve locations in Arizona, Florida, Maryland, Pennsylvania and West Virginia (starting February 3). Modern Flower is available at Trulieve locations in Arizona, Florida, Maryland, Pennsylvania and West Virginia (starting February 10). Both Roll One and Modern Flower are also available at Trulieve’s partner dispensaries in the Northeast.

Trulieve dispensaries in Massachusetts are located in Framingham, Northampton and Worcester. For more information on store activations, promotions and locations, please visit trulieve.com/dispensaries/massachusetts.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established hubs in the Northeast, Southeast, and Southwest, anchored by leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve
Instagram: @Trulieve_
Twitter: @Trulieve

Investor Contact
Christine Hersey, Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Rob Kremer, Executive Director of Corporate Communications
+1 (404) 218-3077
Robert.Kremer@Trulieve.com

SOURCE Trulieve Cannabis Corp.

Company Relationship Disclosure

T420 is responsible for the T420 opinions provided in this disclosure except all sources or information provided by other parties were not verified or authenticated and T420 does not undertake to confirm or substantiate or be responsible for such information provided by other parties.

Any Content posted regarding a Profiled Issuer is not a solicitation or recommendation to buy, sell or hold securities. We cannot and do not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. All information should be independently verified. We are not responsible for errors or omissions in our publications, and any opinions expressed are subject to change, without notice. We do not, nor are we under any obligation to undertake due diligence or investigation or authenticate and verify whatsoever regarding Profiled Issuers or any Content posted in relation thereto and we do not receive any verification from the Profiled Issuer regarding the Content we disseminate. Similarly, while we endeavor to facilitate the provision of quality information, we are not responsible for any loss or damages caused or alleged to have been caused by its use nor verify or authenticate or update such information.

This article contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs regarding future performance are “forward-looking statements”. Forward-looking statements can be identified by the use of words such as “expects”, “does not expect”, “is expected”, “believes”, “intends”, “anticipates”, “does not anticipate”, “believes” or variations of these words, expressions or statements, that certain actions, events or results “may”, “could”, “would”, “might” or “will be” taken, will occur or will be realized. Such forward-looking statements involve risks, uncertainties and other known and unknown factors that could cause actual results, events or developments to differ materially from the results, events or developments expected and expressed or implied in such forward-looking statements. These risks and uncertainties include, but are not limited to, dependence on obtaining and maintaining regulatory approvals, including the acquisition and renewal of federal, provincial, state, municipal, local or other licenses, and any inability to obtain all necessary government authorizations, licenses and permits to operate and expand the Company’s facilities; regulatory or policy changes such as changes in applicable laws and regulations, including federal, state and provincial legalization, due to fluctuations in public opinion, industry perception of integrative mental health, including the use of psychedelic-assisted therapy, delays or inefficiencies or any other reason; any other factor or development likely to hamper the growth of the market; the Company’s limited operating and profitability track record; dependence on management; the Company’s need for additional financing and the effects of financial market conditions and other factors on the availability of capital; competition, including that of more established and better funded competitors; the impact of the Russia-Ukraine conflict on the global economy; the continued impact of the COVID-19 pandemic; and the need to build and maintain alliances and partnerships, including with research and development companies, customers and suppliers. These factors should be carefully considered, and readers are cautioned not to place undue reliance on forward-looking statements. Despite the Company’s efforts to identify the main risk factors that could cause actual measures, events or results to differ materially from those described in forward-looking statements, other risk factors may cause measures, events or developments to materially differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. The Company does not undertake to revise forward-looking statements, even if new information becomes available as a result of future events, new facts or any other reason, except as required by applicable laws

Share

Tags

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Technical420.com. Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.

Top Stories